Oppenheimer & CO Inc Vanda Pharmaceuticals Inc. Transaction History

Oppenheimer & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$13.37 - $18.85 $206,967 - $291,798	-15,480 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$17.59 - $31.05 $3,201 - $5,651	-182 Reduced 1.16%	15,480 $285,000
Q4 2018 Jan 29, 2019	SELL	$18.97 - $31.47 $24,243 - $40,218	-1,278 Reduced 7.54%	15,662 $409,000
Q3 2018 Oct 26, 2018	BUY	$18.25 - $23.0 $309,155 - $389,620	16,940 New	16,940 $389,000

156

45.2M

86.1K

40.8K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.